ADVAGRAF 3 MG CAPSULAS DURAS DE LIBERACION PROLONGADA
ADVAGRAF 3 MG CAPSULAS DURAS DE LIBERACION PROLONGADA
Commercialized
Register Number
07387021
Prescription Type
Diagnóstico Hospitalario
Authorization Date
Jul 23, 2012
Dosage Form
CÁPSULA DURA DE LIBERACIÓN PROLONGADA
Route: VÍA ORAL
Product Details
Detailed information about this CIMA AEMPS approved pharmaceutical product.
Basic Information
Key regulatory and product classification details
Regulatory Details
Register Number07387021
EMA Approved
Yes
Drug Classification
✗
Generic
No
✗
Orphan
No
✗
Biosimilar
No
✓
Commercialized
Yes
CIMA AEMPS Classification
INGREDIENTS (1)
TACROLIMUSActive
Quantity: 3 mg
Name: TACROLIMUS
ATC CLASSIFICATION (3)
L04A
L04AD
L04AD02